Category Archives: New and Social Media

Tracking 10 Healthcare Beat Reporters on Twitter

It is not news that social media has fundamentally changed the way we communicate. Today, we share news, we don’t just read it.  A news cycle is every moment of every day. We rely on people to pitch news to … Continue reading

Posted in New and Social Media | Comments Off on Tracking 10 Healthcare Beat Reporters on Twitter

Postscript – RSS Feeds – Choice Time

Got Google News Alerts set up? A few weeks ago I wrote a posting about the pending shut down of Google Reader that was scheduled (and happened) after July 1.  I noted that it was time for people who, like … Continue reading

Posted in New and Social Media | Comments Off on Postscript – RSS Feeds – Choice Time

Some Digital and Social Media Guidance – FDA Regulation of Pharma Communications in a Digital Era – A White Paper

I have been working to assemble  a data base of  FDA/OPDP Warning and NOV letters spanning the years 2004-present, tracking activity through a number of fields.  The database now includes hundreds of letters and covers nearly 1000 violations cited by … Continue reading

Posted in New and Social Media, Warning Letters | 4 Comments

FDLI Conference on Advertisting and Promotion

The Food and Drug Law Institute held its annual conference on Advertising and Promotion for the Pharmaceutical, Medical Device, Biologic and Veterinary Medicine Industries in Washington, D.C. on October 1 and 2.  I was able to attend sporadically and participated … Continue reading

Posted in FDA Policy, Medical Devices, New and Social Media | 1 Comment

Comparing FDA to Other Federal Health Agencies – A Postscript to FDA, Influence and Twitter

Using the occasion of the announcement by Twitter that it has rebuilt its i-Pad app “from the ground up” to provide an update to last week’s posting on FDA’s twitter feeds and their influence as measured by Kred. Assessing influence … Continue reading

Posted in FDA Image, New and Social Media | Comments Off on Comparing FDA to Other Federal Health Agencies – A Postscript to FDA, Influence and Twitter